Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)

Publisher Website
Google Scholar
Abstract
BACKGROUND It has been postulated that an insulln‐driven increase in plasminogen activator inhibitor‐1 (PAI‐1) levels may link insulin resistance to anovulatory infertility in women with PCOS and that It may place them at increased risk of thromboembolic disease. However, previous studies have been conflicting because many have failed to control for body mass index (BMI) which may affect PAI‐1. The aim of this study was to investigate PAI‐1 activity in women with PCOS and to compare it with unaffected controls of a similar BMI. DESIGN AND PATIENTS 41 Women with Pcos and 25 weight‐matched controls participated in this cross‐sectional study. Patients were evaluated clinically and by pelvic ultrasound and fasting blood samples were taken for haematological and biochemical tests. MEASUREMENTS PAI‐1 activity, insulin, glucose, trlglycerides, total cholesterol, LDL cholesterol, HDL cholesterol, FSH, LH, PRL, testosterone, SHBG, 17–hydroxyprogesterone, plasminogen, fibrinogen (α2 antiplasmin, blood pressure and insulin sensitivity with a homeostasis model assessment (HOMA) computer programme. RESULTS There was no significant difference in BMI or in (log) PAI‐1 activity in women with PCOS compared with controls (BMI 29.5 ± 5.6 vs. 28.4 ± 6.3 kg/m2, P=0.25 and PAI‐12.56 (SD 0.85) vs. 2.14 (SD 0.98) au/ml, P=0.07). The median fasting insulin level was significantly higher (17 (4.6–134.5) vs. 9.6 (3.7–41.5) mU/l, Pvs. 82.8% (21.8–193), Pρ= 0.61), triglycerides (ρ= 0.49) and fasting insulin (ρ= 0.60) and a negative correlation with HDL cholesterol (ρ=−0.46). Triglyceride concentrations showed the most Significant relationship with (log) PAI‐1 activity on multiple regression. 29% of PCO women (12/41) gave a positive family history of thrombosis compared to 8% (2/25) in the control group. CONCLUSION Plasminogen activator inhibitor‐1 activity is not raised in women with PCOS independent of obesity and these results do not support the hypothesis that it may contribute to their anovulatory infertility, or increase their risk of thrombosis. The only significant metabolic features of the PCOS independent of obesity are insulin resistance, hyperinsu‐linaemia and lower HDUtotal cholesterol ratio. The higher frequency of a positive family history of thrombosis in these women nevertheless requires further explanation.

This publication has 12 references indexed in Scilit: